LON:CLIN - Clinigen Group Price Target & Analyst Ratings

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

5 Wall Street analysts have issued ratings and price targets for Clinigen Group in the last 12 months. Their average twelve-month price target is GBX 1,371The high price target for CLIN is GBX 1,640 and the low price target for CLIN is GBX 1,160. There are currently 4 buy ratings and 1 strong buy rating for the stock, resulting in a consensus rating of "Buy."

Clinigen Group (LON:CLIN) Consensus Price Target History

Clinigen Group (LON:CLIN) Analyst Ratings History

Date	Brokerage	Action	Rating	Price Target	Details
9/2/2019	Peel Hunt	Reiterated Rating	Buy
6/26/2019	Peel Hunt	Reiterated Rating	Buy	GBX 1,390
2/27/2019	Numis Securities	Reiterated Rating	Buy	GBX 1,275
2/27/2019	Royal Bank of Canada	Reiterated Rating	Top pick	GBX 1,470 ➝ GBX 1,640
9/27/2018	UBS Group	Reiterated Rating	Buy	GBX 1,160
5/23/2018	Berenberg Bank	Reiterated Rating	Buy	GBX 1,160
1/17/2018	N+1 Singer	Reiterated Rating	Buy	GBX 1,225

(Data available from 9/16/2017 forward)